Osteoporosis in inflammatory bowel disease patients
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study is looking at how common osteoporosis is in people with inflammatory bowel disease (like Crohn's or colitis). It will help doctors understand if bone health screening should be a bigger priority for IBD patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with Crohn's disease or ulcerative colitis.
- You are not already being treated for osteoporosis.
- You are not taking birth control pills.
- You do not have cancer or chronic kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how steroid medicines (called glucocorticoids) affect bone strength in people with long-term inflammatory rheumatic conditions or psoriasis. It may help improve how doctors check and manage osteoporosis risk and bone metabolism over time.
This study tests whether vitamin D supplements can help people with Crohn's disease or ulcerative colitis. You may be able to join if you are between 18 and 85, have IBD, and are not already taking vitamin D or calcium.
This study looks at how Crohn’s disease affects bones and bone marrow soon after diagnosis. It may help researchers understand disease effects and improve future care, either by comparing you to healthy controls or by tracking changes over time.
This trial looks at whether low vitamin D levels are linked to inflammatory bowel disease (Crohn's and ulcerative colitis). It may help understand the role of vitamin D in managing these conditions.
This study looks at body composition (fat and muscle) in people with Crohn's disease or ulcerative colitis. It tests if a new way to monitor body changes can help guide treatment with biologic or JAK inhibitor medicines.
This study follows patients with inflammatory bowel disease (Crohn's or ulcerative colitis) to better understand abnormal growths in the colon (dysplasia) and their risk of turning into cancer. It aims to improve how we predict and prevent cancer in IBD patients.
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.